Overview
Brian Mclaughlin is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Mclaughlin is rated as an Advanced provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), Lung Cancer, and Colorectal Cancer.
His clinical research consists of co-authoring 5 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
9100 Babcock Blvd, Suite G 600, Pittsburgh, PA 15237
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Oncology Hematology Association Inc
John Rhee is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Rhee is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.
UPMC Hillman Cancer Center
Anwaar Saeed, MD, is an Associate Professor of Medicine and the Chief of the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), and UPMC Hillman Cancer Center. She also serves as the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation. Her research efforts are focused on immune modulatory approaches in patients with gastric & esophageal cancer, colon cancer and hepatocellular carcinoma as well as chemoprevention/ immunoprevention in the high-risk GI population. She has published more than 150 peer reviewed papers, posters and book chapters, and have led more than 40 clinical trials, focused on various immune modulatory regimens including but not limited to immune checkpoint inhibitor combinations with chemotherapy, other checkpoint inhibitors, antibody drug conjugates, bi-specific T cell engagers (BiTE), angiogenesis inhibitors, as well as immunotherapy combinations with regional approaches like stereotactic radiosurgery and intensity-modulated radiation therapy. She currently leads several investigator-initiated trials focused on novel targeted immunotherapy combinations including the ongoing phase I/II CAMILLA multicohort study looking at Cabozantinib plus Durvalumab with or without Tremelimumab in GI malignancies. Results from phase I/II part of the CAMILLA led to the development of the currently ongoing global pivotal trial, STELLAR 303, in patients with previously treated microsatellite stable colorectal cancer. She is also the study chair for a soon to open SWOG/intergroup NCI national trial (S2303) testing a novel chemo-immunotherapy regimen in patients with advanced gastric & esophageal adenocarcinoma. Dr. Saeed is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Familial Colorectal Cancer, and Gamma Knife Radiosurgery.
University Of Pittsburgh Physicians
Ibrahim Sahin is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Sahin has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, and Familial Pancreatic Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Colorectal CancerDr. Mclaughlin isDistinguished. Learn about Familial Colorectal Cancer.
- Small Cell Lung Cancer (SCLC)Dr. Mclaughlin isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Mclaughlin isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Mclaughlin isAdvanced. Learn about Anemia.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Mclaughlin isAdvanced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- B-Cell LymphomaDr. Mclaughlin isAdvanced. Learn about B-Cell Lymphoma.
- Breast Cancer in MenDr. Mclaughlin isAdvanced. Learn about Breast Cancer in Men.
- Carcinoid SyndromeDr. Mclaughlin isAdvanced. Learn about Carcinoid Syndrome.
- Experienced
- Acute Eosinophilic PneumoniaDr. Mclaughlin isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Mclaughlin isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Mclaughlin isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Mclaughlin isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Mclaughlin isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Mclaughlin isExperienced. Learn about Adult Immune Thrombocytopenia.

